DexCom (DXCM) Stock News
$DXCM · NASDAQ · HEALTHCARE · 5 stories in 30 daysBORSA has published 5 stories on DexCom (DXCM) in the past 30 days, 1 of them high impact. BORSA’s news read on DXCM is bullish at 70/100, unchanged over 24 hours, based on 5 company events over the past 7 days. DXCM last closed at $79.93 on Oct 29, up 2.06% over five sessions and down 7.37% over the past month. DexCom last reported quarterly results on Jul 30, 2026, for the quarter ended Jun 30, 2026.
The wire on $DXCM
newest first · updated · direct subject stories onlyDexcom rose more than 5% to $84.47 after its third-quarter report showed 11% sales growth, a profit beat, and no pricing degradation, countering Abbott's earlier warning on diabetes wearables. The company raised the bottom and midpoint of full-year sales guidance to $5.2 billion to $5.25 billion and reiterated belief that a Medicare coverage expansion proposal for non-insulin patients will come by year-end.
bullish 80 · impact 60Dexcom reported Q3 revenue of $1.34B (est. $1.33B) and adj. EPS of $0.73 (est. $0.67). The company raised its FY26 revenue guidance to $5.20B-$5.25B. US revenue grew 14% YoY; international grew 5%. Gross margin improved 380 bps to 65.1%. Also announced $1B share repurchase authorization.